Oramed Pharmaceuticals Inc (ORMP)

09:02 AM

Oramed Pharm and Scilex Finalize Option Agreement - TipRanks

09:02 AM

08:40 AM

Oramed Pharmaceuticals enters option agreement with Scilex for warrant repurchase - MarketScreener

08:40 AM

Jul 22, 2025

What analysts say about Oramed Pharmaceuticals Inc. stockSkyrocketing profit margins - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Oramed Pharmaceuticals Inc. a good long term investmentAccelerated capital growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Oramed Pharmaceuticals Inc. Stock Analysis and ForecastConsistent high-yield stocks - Autocar Professional

Jul 22, 2025

Jul 22, 2025

What drives Oramed Pharmaceuticals Inc. stock priceExceptional financial outcomes - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Oral Proteins & Peptides Market to Surge to US$24 Billion by 2030, Driven by Chronic Disease Burden and Drug Delivery Innovation - Barchart.com

Jul 21, 2025

Jul 15, 2025

What makes Oramed Pharmaceuticals Inc. stock price move sharplyFree Group Entry - Newser

Jul 15, 2025

Jul 15, 2025

Why Oramed Pharmaceuticals Inc. stock attracts strong analyst attentionRisk Managed Trading Strategy - Newser

Jul 15, 2025

Jul 15, 2025

How Oramed Pharmaceuticals Inc. stock performs during market volatilityFree Investment Community - Newser

Jul 15, 2025

Jul 10, 2025

Head to Head Survey: Oramed Pharmaceuticals (NASDAQ:ORMP) and Smith & Nephew SNATS (NYSE:SNN) - Defense World

Jul 10, 2025

Jun 23, 2025

Alpha Tau Medical's $36.9M Financing: A Strategic Leap Toward Revolutionary Cancer Therapy - AInvest

Jun 23, 2025

Jun 12, 2025

Oramed Pharmaceuticals : Announces Xiaoming Gao Joins Board of Directors - marketscreener.com

Jun 12, 2025

Jun 04, 2025

Oral Biologics Market Outlook 2025: Rising Demand, Market Size, - openPR.com

Jun 04, 2025

Jun 04, 2025

Two Sigma Advisers LP Invests $662,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World

Jun 04, 2025

May 28, 2025

Type 2 Diabetes Pipeline 2025: Therapies Under Investigation, - openPR.com

May 28, 2025

May 28, 2025

Oral Biologics Market in 2025-2032 Detailed Study Analysis with - openPR.com

May 28, 2025

May 28, 2025

Alpha Tau to Present at Jefferies Global Healthcare Conference - Stock Titan

May 28, 2025

May 28, 2025

Acusphere (OTCMKTS:ACUS) versus Oramed Pharmaceuticals (NASDAQ:ORMP) Critical Comparison - Defense World

May 28, 2025

May 27, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Below 200-Day Moving Average – Should You Sell? - Defense World

May 27, 2025

May 21, 2025

Oramed Pharm Extends Stock Buyback Program - TipRanks

May 21, 2025

May 18, 2025

Dimensional Fund Advisors LP Grows Stake in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) - Defense World

May 18, 2025

May 17, 2025

The past three years for Oramed Pharmaceuticals (NASDAQ:ORMP) investors has not been profitable - Yahoo Finance

May 17, 2025

May 17, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Rating Lowered by StockNews.com - Defense World

May 17, 2025

May 15, 2025

Oramed: Q1 Earnings Snapshot - New Haven Register

May 15, 2025

May 13, 2025

Alpha Tau Medical appoints new board member By Investing.com - Investing.com India

May 13, 2025

May 12, 2025

Alpha Tau Medical appoints new board member - Investing.com

May 12, 2025

May 12, 2025

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors - GlobeNewswire

May 12, 2025

May 09, 2025

StockNews.com Downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) to Sell - Defense World

May 09, 2025

May 05, 2025

Renaissance Technologies LLC Trims Position in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) - Defense World

May 05, 2025